IL6 and lobular neoplasia: While underlying mechanism for the observed efficacy of IL-6 blockade therapies are yet to be uncovered, the paradigm that IL-6 is associated with disease initiation and progression stands challenged by recent observations from Steinmetz and colleagues for a protective role of IL-6 in LN (Hagenstein et al., 2019).